Legend: Boston Convention & Exhibition Center = CC, Westin Boston Waterfront = W, Seaport Boston Hotel = S
A * preceding a session name means that the session is an applied session.
A ! preceding a session name means that the session reflects the JSM meeting theme.
A * preceding a session name means that the session is an applied session.
A ! preceding a session name means that the session reflects the JSM meeting theme.
Activity Details
|
|
Tweet | ||
| 277 * ! | Tue, 8/5/2014, 8:30 AM - 10:20 AM | CC-153A | |
| Designs and Analyses of Studies with Small Sample Sizes — Topic Contributed Papers | |||
| Biopharmaceutical Section | |||
| Organizer(s): Junshan Qiu, FDA | |||
| Chair(s): Anna B. Nevius, FDA | |||
| 8:35 AM | Utility-Based Optimization of Schedule-Dose Regimes Based on the Times to Response and Toxicity — Peter Thall, MD Anderson Cancer Center ; Hoang Q. Nguyen, MD Anderson Cancer Center ; Tom Braun, University of Michigan ; Muzaffar Qazilbash, MD Anderson Cancer Center | ||
| 8:55 AM | Challenges in Designing Clinical Trials for Rare Diseases — Christopher Coffey, University of Iowa ; Eric Foster, University of Iowa | ||
| 9:15 AM | A One-To-Two Arm Design for a Rare Disease — Todd Graves, Berry Consultants | ||
| 9:35 AM | Extension of Population Pharmacokinetic Models and Optimal Sparse Sampling Designs to Bioequivalence Study Designs — Junshan Qiu, FDA ; Mark Fitzgerald, Berry Consultants | ||
| 9:55 AM | Discussant: Gregory Campbell, FDA | ||
| 10:15 AM | Floor Discussion | ||
2014 JSM Online Program Home
For information, contact jsm@amstat.org or phone (888) 231-3473.
If you have questions about the Professional Development program, please contact the Education Department.
The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.
Copyright © American Statistical Association.